Table 1. HBV genetic diversity in three infected individuals characterized by sequencing whole genome PCR products using three different methods.
Sample | HBV genotype | Direct Sanger sequencing | Molecular cloning | Direct MinION sequencing |
---|---|---|---|---|
B5584 | D1/E | Max. sequence length: 3,209-nt | Max. sequence length: 3,209-nt | Max. sequence length: 3,201 nt |
D1/E recombinant sequence | Individual D1/E recombinant sequences | Individual D1/E recombinant sequences | ||
Single nucleotide ambiguities across whole genome | D1 and E parental sequences not detected | D1 and E parental sequences not detected | ||
Single nucleotide ambiguities across whole genome* | ||||
1,229-nt deletion (pos. 2,471–489)—putative spliced variant | ||||
B6505 | A2 | Max. sequence length: 3,220-nt | Not done | Max. sequence length: 3,217-nt |
Mixed population of wild-type and single nucleotide mutant S sequences | Mixed population of wild-type and single nucleotide mutant S sequences | |||
Evaluation of mutation association patterns | ||||
1,049-nt deletion (pos. 2,447–282)—putative spliced variant | ||||
96-nt deletion (pos. 2,131–2,226) | ||||
B6260 | D2 | Overlapping sequence signals suggesting at least 2 sequences coexisting | Individual wild-type sequences (3,179-nt) | Max. sequence length: 3,015-nt |
Single nucleotide ambiguities across whole genome | Individual sequence (3,032-nt) with 123-nt (pos. 2,929–3,051) and 24-nt (pos. 501–524) deletions | Individual wild-type sequences | ||
Individual sequences with 123-nt (pos. 2,929–3,051) deletion | ||||
Individual sequences with 123-nt (pos. 2,929–3,051) and 24-nt (pos. 501–524) deletions | ||||
Single nucleotide ambiguities across whole genome* |
* Single nucleotide sequence ambiguities were not investigated further.
Abbreviations: gt, genotype; nt, nucleotide; pos, position.